137 results
Page 2 of 7
6-K
EX-99
0bulaqjf em4k
18 Nov 21
BioLineRx Reports Third Quarter 2021 Financial Results
7:16am
6-K
EX-99
kz94ckpt
18 Nov 21
BioLineRx Reports Third Quarter 2021 Financial Results
7:16am
6-K
EX-99
4u3v5g
27 Oct 21
2021 Annual General Meeting of Shareholders
5:05pm
6-K
EX-99
8sllw1al xel7td
13 Oct 21
BioLineRx Announces Positive Results from
8:37am
424B5
q4h4t
3 Sep 21
Prospectus supplement for primary offering
4:29pm
6-K
EX-99
d70b8a8bmwm4ik6
18 Aug 21
BioLineRx Reports Second Quarter 2021 Financial Results
7:01am
6-K
EX-99
nhwu41ycl q867b0
26 May 21
BioLineRx Reports First Quarter 2021 Financial Results
7:54am
POS AM
72feb21gdbwcrkeov88q
23 Feb 21
Prospectus update (post-effective amendment)
9:12am
6-K
EX-99
q1w5d642zck 2ed
23 Feb 21
BioLineRx Reports Year-End 2020 Financial Results
7:02am
424B5
7uh89pmr4yj82zzh
21 Jan 21
Prospectus supplement for primary offering
4:31pm
424B5
qhzt6
19 Jan 21
Prospectus supplement for primary offering
5:00pm
F-3
mx6t41u54qh4s3z
31 Dec 20
Shelf registration (foreign)
4:37pm
424B5
ttsf b13g
31 Dec 20
Prospectus supplement for primary offering
4:31pm
6-K
EX-99
iyw7n636nzsq
16 Dec 20
Current report (foreign)
8:00am
6-K
EX-99
s79i1l5
23 Nov 20
BioLineRx Reports Third Quarter 2020 Financial Results
7:08am
424B5
ts86l ixvht3ogu
13 Nov 20
Prospectus supplement for primary offering
4:31pm
424B5
lbj57gj 87rl3i5rr
25 Sep 20
Prospectus supplement for primary offering
4:30pm
6-K
EX-99
mhc3d 5yeu
19 Aug 20
2020 Annual General Meeting of Shareholders
4:34pm
POS AM
3c0ul9 1hsitqjv
10 Aug 20
Prospectus update (post-effective amendment)
12:00am